维普中文期刊产品整合服务
97篇 您的检索式:作者名="Eriksson LC"
    题名 作者 年代 出处 被引量
1Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty显示文摘Eriksson BI Borris LC Friedman RJ 0,,26:1
2Rivaroxaban versus enoxaparin for thromboprophylaxis after hip anthroplasty显示文摘Eriksson BI Borris LC Friedman RJ 2008N EnglJ Med2008,358,:1
3Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthropl asty 显示文摘ERIKSSON BI BORRIS LC FRIEDMAN RJ 2008N Engl J Med2008,358,26:1
4A once-daily,oral,direct factor Xa inhibitor,rivaroxaban (BAY 5927939),for thromboprophylaxis after total hip replacement显示文摘Eriksson BI Borris LC Dahl OE 0,,:1
5Rivaroxaban versus enox- aparin for thromboprophylaxis after hip arthroplasty显示文摘Eriksson BI Borris LC Friedman RJ 2008N Engl J Med2008,358,26:1
6Rivaroxaban versus enox- aparin for thromboprophylaxis after hip arthroplasty 显示文摘Eriksson BI Borris LC Friedman RJ 2008N Engl JMed2008,358,26:1
7Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty显示文摘Eriksson BI Borris LC Friedman RJ 2008N Engl J Mea2008,358,26:1
8A once-daily,oral,direct Factor Xa inhibitor,rivaroxaban (BAY 59-7939),for thromboprophylaxis after total hip replacement显示文摘Eriksson BI Borris LC Dahl OE 2006Circulation2006,114,22:1
9Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty显示文摘Eriksson BI Bon'is LC Friedman RJ 2008N En- gl J Med2008,358,26:1
10Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthro- plasty显示文摘Eriksson BI Borris LC Fri edman RJ et a/ 2008N Engl J Med2008,358,26:1
11DNA ploidy and S -phase fraction in carcinoma of the gallbladder related to histopathology,number of gallstones and survival显示文摘Gustafsson U Einarsson C Eriksson LC 2001Anal Cell Pathol2001,23,34:1
12Genetic approach to the role of cysteine proteases in the expansion of abdominal aortic an- eurysms显示文摘Eriksson P Jones KG Brown LC 2004Br J Surg2004,91,1:1
13Rivaroxa ban versus enoxaparin for thromboprophylaxis after hip arthroplasty显示文摘Eriksson BI Borris LC Friedman RJ 2008N Engl J Med2008,358,26:1
14Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthro- plasty显示文摘Eriksson BI Borris LC Friedman R J 2008N Engl J Med2008,358,26:1
15Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplas- ty 显示文摘Eriksson BI Borris LC Friedman ILl 2008N Engl J Med2008,358,:1
16Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty显示文摘Eriksson BI Borris LC Friedman RJ 2008N Engl J Med2008,358,26:1
17Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty显示文摘Eriksson BI Borris LC Friedman RJ 2008N Engl J Med2008,358,26:1
18Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty显示文摘Eriksson BI Borris LC Friedman RJ 2008N Engl J Med2008,358,26:1
19Growth hormone administration after treatment in the resistant hepatocyte model does not affect progression of rat liver carcinogenesis显示文摘Blanck A Assefaw-Redda Y Eriksson LC 1994Cancer Lett1994,79,2:1
20Decreased expression of the growth hormone receptor and growth hormone binding protein in rat liver nodules显示文摘Levinovitz A Husman B Eriksson LC 1990Mol Carcinog1990,3,3:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费